North Carolina Central University will dedicate its $20 million Biomanufacturing Research Institute and Technology Enterprise facility on June 9.
The facility, which covers 52,000 square feet, was funded by Golden LEAF, an economic development foundation that is responsible for managing half the funds North Carolina receives as part of the national tobacco lawsuit settlement.
The institute, which goes by the acronym BRITE, will be used to train biotechnology and biomanufacturing workers. It includes classrooms, laboratory and office space.
“BRITE is dedicated to providing biotech and pharmaceutical sciences education to our North Carolina Central University students,” said NCCU Chancellor Charlie Nelm. “Our goal is to provide BRITE students with an education and skill set that will give them a strong competitive advantage in the biotech/biomanufacturing workplace. This is accomplished through innovation in curriculum developed by BRITE faculty and strategic placement of students in industrial internships.”
Faculty is being recruited from biotech and pharmaceutical companies.
BRITE is part of the NCBioImpact, a statewide job-force development partnership that includes Golden LEAF, the Biotech Training & Education Center on N.C. State’s Centennial Campus, the North Carolina Biotechnology Center, the North Carolina Community College System BioNetwork and the North Carolina Bioscience Organization.